Literature DB >> 18682938

Oesophageal cancer: can imaging improve its assessment?

Giovanni Lucignani1.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18682938     DOI： 10.1007/s00259-008-0884-0

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  15 in total

Review 1.  PET/CT of esophageal cancer: its role in clinical management.

Authors:  John F Bruzzi; Reginald F Munden; Mylene T Truong; Edith M Marom; Bradley S Sabloff; Gregory W Gladish; Revathy B Iyer; Tin-Su Pan; Homer A Macapinlac; Jeremy J Erasmus
Journal:  Radiographics       Date:  2007 Nov-Dec       Impact factor: 5.333

2.  Pre-operative estimation of esophageal tumor metabolic length in FDG-PET images with surgical pathology confirmation.

Authors:  Marcelo Mamede; Georges El Fakhri; Paula Abreu-e-Lima; William Gandler; Vânia Nosé; Victor H Gerbaudo
Journal:  Ann Nucl Med       Date:  2007-12-25       Impact factor: 2.668

3.  Does FDG-PET add information to EUS and CT in the initial management of esophageal cancer? A prospective single center study.

Authors:  Patrick B McDonough; David R Jones; K R Shen; Patrick G Northup; Roman L Galysh; Alfredo Hernandez; Grace E White; Michel Kahaleh; Vanessa M Shami
Journal:  Am J Gastroenterol       Date:  2007-10-17       Impact factor: 10.864

4.  18FDG uptake in oesophageal adenocarcinoma: linking biology and outcome.

Authors:  Marinke Westerterp; Gerrit W Sloof; Otto S Hoekstra; Fiebo J W Ten Kate; Gerrit A Meijer; Johannes B Reitsma; Ronald Boellaard; J Jan B van Lanschot; Carla F M Molthoff
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-25       Impact factor: 4.553

5.  Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma.

Authors:  Andre A Konski; Jonathan D Cheng; Melvyn Goldberg; Tianyu Li; Alan Maurer; Jian Q Yu; Oleh Haluszka; Walter Scott; Neal J Meropol; Steven J Cohen; Gary Freedman; Louis M Weiner
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-05-29       Impact factor: 7.038

6.  Limited additional value of positron emission tomography in staging oesophageal cancer.

Authors:  H L van Westreenen; M Westerterp; G W Sloof; H Groen; P M M Bossuyt; P L Jager; E F Comans; H M van Dullemen; P Fockens; J Stoker; E J van der Jagt; J J B van Lanschot; J T M Plukker
Journal:  Br J Surg       Date:  2007-12       Impact factor: 6.939

Review 7.  Added value of PET and PET-CT in oesophageal cancer: a review of current practice.

Authors:  Sobhan Vinjamuri; Soumendranath Ray
Journal:  Nucl Med Commun       Date:  2008-01       Impact factor: 1.690

8.  Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.

Authors:  I E Katsoulis; W L Wong; A K Mattheou; N Damani; J Chambers; J I Livingstone
Journal:  Int J Surg       Date:  2007-06-03       Impact factor: 6.071

9.  Staging investigations for oesophageal cancer: a meta-analysis.

Authors:  E P M van Vliet; M H Heijenbrok-Kal; M G M Hunink; E J Kuipers; P D Siersema
Journal:  Br J Cancer       Date:  2008-01-22       Impact factor: 7.640

Review 10.  Staging of oesophageal cancer.

Authors:  Stefan Diederich
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.